Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma

Yale J Biol Med. 2010 Mar;83(1):27-33.
Shaib W1, Mitchell K, Saif MW.
Yale J Biol Med. 2010 Mar;83(1):27-33.
Trattamento di tumori delle cellule insulari secernenti polipeptide intestinale vasoattivo (VIPomi) con chemioembolizzazione di una lesione epatica metastatica rispondente ad un aumento della dose di octreotide.
Octreotide/tumori delle cellule insulari pancreatiche.

Vasoactive intestinal polypeptide secreting islet cell tumors (VIPomas) are neuroendocrine tumors that secrete excessive amounts of vasoactive intestinal polypeptide (VIP) that cause distinct syndromes characterized by large-volume diarrhea, hypokalemia, and dehydration. The annual incidence of these tumors is estimated to be about one per 10,000,000 individuals in the general population. We report a successful treatment of VIPoma with hepatic chemoembolization of a metastatic hepatic lesion evidenced by a reduction of VIP levels and resolutions of symptoms in a patient with pancreatic VIPoma unresponsive to increased doses of an octreotide analog.
Free PMC Article